NewFocus Financial Group’s Quest Diagnostics DGX Stock Holding History

NewFocus Financial Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$2.23M	Buy	18,733 +1,369	+8%	+$167K	0.66%	43
2020 Q3	$1.99M	Buy	17,364 +1,977	+13%	+$234K	0.66%	44
2020 Q2	$1.75M	Buy	15,387 +1,950	+15%	+$207K	0.63%	43
2020 Q1	$1.08M	Buy	13,437 +745	+6%	+$77.1K	0.5%	48
2019 Q4	$1.35M	Sell	12,692 -105	-0.8%	-$10.9K	0.53%	44
2019 Q3	$1.37M	Buy	12,797 +545	+4%	+$55.9K	0.6%	44
2019 Q2	$1.25M	Buy	12,252 +734	+6%	+$70.5K	0.58%	44
2019 Q1	$1.04M	Sell	11,518 -195	-2%	-$16.9K	0.52%	45
2018 Q4	$975K	Sell	11,713 -8,086	-41%	-$758K	0.58%	42
2018 Q3	$2.14M	Buy	+19,799	New	+$2.17M	1.15%	28

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NewFocus Financial Group's DGX Position: Q4 2020 in Review

NewFocus Financial Group increased its Quest Diagnostics (DGX) stake by 7.9% in Q4 2020, buying an estimated $167K and bringing the position to 18,733 shares worth $2.23M. The position accounts for 0.66% of the portfolio, ranked #43.

NewFocus Financial Group first reported a position in DGX in Q3 2018 and has held it in 10 quarters since. 812 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

NewFocus Financial Group held 18,733 shares of Quest Diagnostics worth $2.23M as of Q4 2020.
NewFocus Financial Group bought 1,369 Quest Diagnostics shares in Q4 2020, an estimated $167K.
Quest Diagnostics made up 0.66% of NewFocus Financial Group's portfolio in Q4 2020, its #43 holding.
NewFocus Financial Group first reported a position in Quest Diagnostics in Q3 2018 and has held it in 10 quarters since.
812 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on NewFocus Financial Group's 13F filing for Q4 2020, filed 28 Jan 2021.